DrugPatentWatch Database Preview
Litigation Details for LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)
Email this page to a colleague
See Plans and PricingLEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)
| Docket | Start Trial | Date Filed | 2016-05-06 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | |
| Parties | ACTAVIS LABORATORIES UT, INC.; ACTAVIS, INC.; ALLERGAN FINANCE LLC; LEO LABORATORIES LIMITED; LEO PHARMA A/S; LEO PHARMA, INC. | ||
| Patents | 6,432,452; 6,787,161; 6,844,013; 7,410,656; 8,278,292; 8,372,827; 8,372,828; 8,377,919; 8,536,163; 8,716,271; 8,735,375 | ||
| Attorneys | Jack B. Blumenfeld; James L. Higgins; Maryellen Noreika; Melanie K. Sharp; Robert M. Vrana | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in LEO Pharma A/S v. Actavis Laboratories UT, Inc.
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-05-06 | 1 | of U.S. Patent No. 7,410,656 (“the ’656 Patent”), U.S. Patent No. 8,278,292 (“the ’292 Patent”), U.S.…the ’656 Patent, ’292 Patent, the ’827 Patent, the ’828 Patent, the ’919 Patent, the ’163 Patent, the ’…U.S. Patent No. 8,372,827 (“the ’827 Patent”), U.S. Patent No. 8,372,828 (“the ’828 Patent”), U.S. Patent…8,377,919 (“the ’919 Patent”), U.S. Patent No. 8,536,163 (“the ’163 Patent”), U.S. Patent No. …the ’271 Patent”), and U.S. Patent No. 8,735,375 (“the ’375 Patent”) (collectively, “the Patents-in-Suit | External link to document | |
| 2016-07-21 | 15 | of U.S. Patent No. 7,410,656 (“the ’656 Patent”), U.S. Patent No. 8,278,292 (“the ’292 Patent”), U.S. …Declaratory Judgment of Invalidity of U.S. Patent No. 7,410,656) 17. Actavis realleges and incorporates…Declaratory Judgment of Noninfringement of U.S. Patent No. 7,410,656) 29. Actavis realleges and incorporates…. Patent No. 8,372,827 (“the ’827 Patent”), U.S. Patent No. 8,372,828 (“the ’828 Patent”), U.S. Patent…8,377,919 (“the ’919 Patent”), U.S. Patent No. 8,536,163 (“the ’163 Patent”), U.S. Patent No. 8,716,271 (“ | External link to document | |
| 2017-12-28 | 203 | ' 161 patent and the '013 patent claim priority to parent U.S. Patent No. 6,432,452 ("the…;828 patent, the '919 patent, the '163 patent, the '271 patent, the '375 patent, the … '013 patent), as well as the '656 patent, the '292 patent, the '827 patent, the '…The Aylward patents include the '656 patent, the '013 patent, and the' 161 patent. (D.I. 142… The Brown patents include the '292 patent, the '827 patent, the '828 patent, the '919 | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
